Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

AZD-2171 useful in combination with other antitumor agents

Oct. 4, 2004

Metvix approved in eight more European countries

Oct. 4, 2004

Cellular Genomics presents new Hsp90 modulators

Oct. 4, 2004

Millennium submits supplemental NDA for Velcade

Oct. 1, 2004

Pharmacyclics identifies potential development candidate from a series of sapphyrin derivatives

Oct. 1, 2004

Novel VEGFR2/PDGFR kinase inhibitor with antitumor and antiangiogenic activity presented by Bayer

Oct. 1, 2004

Inhibition of SOD1 via copper depletion results in inhibition of angiogenesis

Oct. 1, 2004

ABP-309: a second-generation VEGFR tyrosine kinase inhibitor with a promising preclinical profile

Oct. 1, 2004

First clinical results reported for AMG-706 in patients with advanced tumors

Oct. 1, 2004

Selective inhibitors of PKB/Akt designed at Astex

Oct. 1, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...